BACKGROUND: Emerging evidence suggests that "fibroblast-like cells" (FLC) may play a role in the regulation of gastrointestinal (GI) motor function. FLC are ultrastructurally distinct from other interstitial cells, including interstitial cells of Cajal (ICC), and express small-conductance Ca(2+) -activated K(+) channels (SK3). In mice, platelet-derived growth factor receptor α (PDGFRα) antibody has also been shown to label FLC. The aims of this study were to determine the morphology and distribution of PDGFRα-immunoreactive (ir) FLC in human gastric muscle and to determine if FLC are altered in gastroparesis, where ICC are reduced. METHODS: Full thickness gastric body biopsies from five healthy subjects, 10 diabetic, and 10 idiopathic gastroparesis patients were immunolabeled using SK3 and PDGFRα staining for FLC and Kit staining for ICC. Intramuscular FLC and ICC were quantified. KEY RESULTS: Intramuscular PDGFRα-ir cells had slender cell bodies and long, thin processes and were more abundant in the longitudinal compared with the circular muscle. In the region of myenteric plexus, FLC had smaller, rounder cell bodies with 3-4 processes and formed networks, often around ganglia. All SK3-ir cell structures showed complete overlap with PDGFRα-ir. FLC were in close proximity to ICC, but their cell bodies did not overlap. No differences were seen in the distribution, morphology, or overall numbers of FLC in gastroparesis patients. CONCLUSIONS & INFERENCES: In conclusion, PDGFRα identifies FLC in human gastric smooth muscle. FLC were not altered in distribution or overall numbers in gastroparesis. Additional studies are required to determine their role in human GI function.
BACKGROUND: Emerging evidence suggests that "fibroblast-like cells" (FLC) may play a role in the regulation of gastrointestinal (GI) motor function. FLC are ultrastructurally distinct from other interstitial cells, including interstitial cells of Cajal (ICC), and express small-conductance Ca(2+) -activated K(+) channels (SK3). In mice, platelet-derived growth factor receptor α (PDGFRα) antibody has also been shown to label FLC. The aims of this study were to determine the morphology and distribution of PDGFRα-immunoreactive (ir) FLC in humangastric muscle and to determine if FLC are altered in gastroparesis, where ICC are reduced. METHODS: Full thickness gastric body biopsies from five healthy subjects, 10 diabetic, and 10 idiopathic gastroparesispatients were immunolabeled using SK3 and PDGFRα staining for FLC and Kit staining for ICC. Intramuscular FLC and ICC were quantified. KEY RESULTS: Intramuscular PDGFRα-ir cells had slender cell bodies and long, thin processes and were more abundant in the longitudinal compared with the circular muscle. In the region of myenteric plexus, FLC had smaller, rounder cell bodies with 3-4 processes and formed networks, often around ganglia. All SK3-ir cell structures showed complete overlap with PDGFRα-ir. FLC were in close proximity to ICC, but their cell bodies did not overlap. No differences were seen in the distribution, morphology, or overall numbers of FLC in gastroparesispatients. CONCLUSIONS & INFERENCES: In conclusion, PDGFRα identifies FLC in human gastric smooth muscle. FLC were not altered in distribution or overall numbers in gastroparesis. Additional studies are required to determine their role in human GI function.
Authors: Masaaki Kurahashi; Haifeng Zheng; Laura Dwyer; Sean M Ward; Sang Don Koh; Kenton M Sanders Journal: J Physiol Date: 2010-12-20 Impact factor: 5.182
Authors: Caroline A Cobine; Grant W Hennig; Masaaki Kurahashi; Kenton M Sanders; Sean M Ward; Kathleen D Keef Journal: Cell Tissue Res Date: 2011-02-22 Impact factor: 5.249
Authors: Madhusudan Grover; Gianrico Farrugia; Matthew S Lurken; Cheryl E Bernard; Maria Simonetta Faussone-Pellegrini; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Ünalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Pankaj J Pasricha Journal: Gastroenterology Date: 2011-02-04 Impact factor: 22.682
Authors: Y Zhang; S A Carmichael; X Y Wang; J D Huizinga; W G Paterson Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-10-22 Impact factor: 4.052
Authors: Maria Simonetta Faussone-Pellegrini; Madhusudan Grover; Pankaj J Pasricha; Cheryl E Bernard; Matthew S Lurken; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Unalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Gianrico Farrugia Journal: J Cell Mol Med Date: 2012-07 Impact factor: 5.310
Authors: Bettina Schwamb; Robert Pick; Sara Beatriz Mateus Fernández; Kirsten Völp; Jan Heering; Volker Dötsch; Susanne Bösser; Jennifer Jung; Rasa Beinoraviciute-Kellner; Josephine Wesely; Inka Zörnig; Matthias Hammerschmidt; Matthias Nowak; Roland Penzel; Kurt Zatloukal; Stefan Joos; Ralf Joachim Rieker; Abbas Agaimy; Stephan Söder; K Marie Reid-Lombardo; Michael L Kendrick; Michael R Bardsley; Yujiro Hayashi; David T Asuzu; Sabriya A Syed; Tamas Ordog; Martin Zörnig Journal: Int J Cancer Date: 2015-03-12 Impact factor: 7.396
Authors: Masaaki Kurahashi; Yasuko Nakano; Lauren E Peri; Jared B Townsend; Sean M Ward; Kenton M Sanders Journal: Am J Physiol Gastrointest Liver Physiol Date: 2013-02-21 Impact factor: 4.052
Authors: Salah A Baker; Grant W Hennig; Anna K Salter; Masaki Kurahashi; Sean M Ward; Kenton M Sanders Journal: J Physiol Date: 2013-10-21 Impact factor: 5.182
Authors: B P Herring; A M Hoggatt; A Gupta; S Griffith; A Nakeeb; J N Choi; M T Idrees; T Nowak; D L Morris; J M Wo Journal: Neurogastroenterol Motil Date: 2017-10-20 Impact factor: 3.598
Authors: Michael Camilleri; Victor Chedid; Alexander C Ford; Ken Haruma; Michael Horowitz; Karen L Jones; Phillip A Low; Seon-Young Park; Henry P Parkman; Vincenzo Stanghellini Journal: Nat Rev Dis Primers Date: 2018-11-01 Impact factor: 52.329